Epstein-barr virus and p16INK4A methylation in squamous cell carcinoma and precancerous lesions of the cervix uteri

Journal of Korean Medical Science

Volumn 20, Issue 4, 2005, Pages 636-642

  Na, Rae Kim ^a   Lin, Zhenhua ^b   Kyong, Rae Kim ^c   Hyun, Yee Cho ^a   Kim, Insun ^b  

^a Gachon University College of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Konkuk University   (South Korea)

Author keywords

Carcinogenesis; Cervix Neoplasms; Epstein Barr Virus Infections; Herpesvirus 4, Human; Methylation; Protein p16

Indexed keywords

EID: 24644488431     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2005.20.4.636     Document Type: Article

References (38)

1. Nuovo GJ, Plaia TW, Belinsky SA, Baylin SB, Herman JG. In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis. Proc Natl Acad Sci USA 1999; 96: 12754-9.
2. INK4A in primary gynecologic malignancy. Cancer Lett 1999; 136: 231-5.
3. Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, Sidransky D, Baylin SB. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 1995; 55: 4525-30.
4. Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol 1998; 153: 1741-8.
5. Baylin SB, Esteller M, Rountree MR, Bachman KE, Schuebel K, Herman JG. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum Mol Genet 2001; 10: 687-92.
6. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/ MTS1 in human cancers. Nat Med 1995; 1: 686-92.
7. Keating JT, Ince T, Crum CP. Surrogate biomarkers of HPV infection in cervical neoplasia screening and diagnosis. Adv Anat Pathol 2001; 8: 83-92.
8. INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol 2001; 25: 884-91.
9. Landers RJ, O'Leary JJ, Crowley M, Healy I, Annis P, Burke L, O'Brien D, Hogan J, Kealy WF, Lewis FA. Epstein-Barr virus in normal, pre-malignant and malignant lesions of the uterine cervix. J Clin Pathol 1993; 46: 931-5.
10. Taylor Y, Melvin WT, Sewell HF, Flannelly G, Walker F. Prevalence of Epstein-Barr virus in the cervix. J Clin Pathol 1994; 47: 92-3.
11. Sasagawa T, Shimakage M, Nakamura M, Sakaike J, Ishikawa H, Inoue M. Epstein-Barr virus (EBV) genes expression on cervical intraepithelial neoplasia and invasive cervical cancer: a comparative study with human papillomavirus (HPV) infection. Hum Pathol 2000; 31: 318-26.
12. Noel J, Lespagnard L, Fayt I, Verhest A, Dargent J. Evidence of human papilloma virus infection but lack of Epstein-Barr virus in lymphoepithelioma- like carcinoma of uterine cervix: report of two cases and review of the literature. Hum Pathol 2001; 32: 135-8.
13. Shibosawa E, Tsutsumi K, Koizuka I, Hoshikawa M, Takakuwa T. Absence of nuclear p16 from Epstein-Barr virus-associated undifferentiated nasopharyngeal carcinomas. Laryngoscope 2000; 110: 93-7.
14. Schneider BG, Gulley ML, Eagan P, Bravo JC, Mera R, Geradts J. Loss of p16/CDKN2A tumor suppressor protein in gastric adenocarcinoma is associated with Epstein-Barr virus and anatomic location in the body of the stomach. Human Pathol 2000; 31: 45-50.
15. Kang GH, Lee S, Kim WH, Lee HW, Kim JC, Rhyu MG, Ro JY. Epstein-barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma. Am J Pathol 2002; 160: 787-94.
16. Cho NH, Kim YT, Kim JW. Alteration of cell cycle in cervical tumor associated with human Papillomavirus: Cyclin-dependent kinase inhibitors. Yonsei Med J 2002; 43: 722-8.
17. Kim IS, Kang JS, Choi AN, Kim YS. The prevalence of Epstein-Barr virus in uterine cervical cancer: Detection by PCR and in situ PCR methods. Korean J Obstet Gynecol 2000; 43: 184-91.
18. Jeong HJ, Lee ES, Lin ZH, Park SH, Kim IS, Kang JS. Detection of Epstein-Barr virus in the inflammatory and neoplastic uterine cervical lesions. Korean J Cytopathol 2001; 12: 73-80.
19. Doyle JJ, Doyle JL. A rapid DNA isolation procedure for small quantities of fresh leaf tissue. Phytochem Bull 1987; 19: 11-5.
20. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad USA 1996; 93: 9821-6.
21. INK4A in archival human solid tumors: correlation with retinoblastoma protein expression. Cancer Res 1995; 55: 6006-11.
22. Coates PJ, d'Ardenne AJ, Khan G, Kangro HO, Slavin G. Simplified procedures for applying the polymerase chain reaction to routinely fixed paraffin wax sections. J Clin Pathol 1991; 44: 115-8.
23. Chang KL, Chen YY, Shibata D, Weiss LM. Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues. Diagn Mol Pathol 1992; 1: 246-55.
24. Virmani AK, Muller C, Rathi A, Zoechbauer-Mueller S, Mathis M, Gazdar AF. Aberrant methylation during cervical carcinogenesis. Clin Cancer Res 2001; 7: 584-9.
25. Wong YF, Chung TK, Cheung TH, Nobori T, Yim SF, Lai KW, Phil M, Yu AL, Diccianni MB, Li TZ, Chang AM. p16INK4 and p15INK4B alterations in primary gynecologic malignancy. Gynecol Oncol 1997; 65: 319-24.
26. Salem C, Liang G, Tsai YC, Coulter J, Knowles MA, Feng AC, Groshen S, Nichols PW, Jones PA. Progressive increases in de novo methylation of CpG islands in bladder cancer. Cancer Res 2000; 60: 2473-6.
27. Yuen PW, Man M, Lam KY, Kwong YL. Clinicopathological significance of p16 gene expression in the surgical treatment of head and neck squamous cell carcinomas. J Clin Pathol 2002; 55: 58-60.
28. Villuendas R, Sanchez-Beato M, Martinez JC, Saez AI, Martinez-Delgado B, Garcia JF, Mateo MS, Sanchez-Verde L, Benitez J, Martinez P, Piris MA. Loss of p16/INK4A protein expression in non-Hodgkin's lymphomas is a frequent finding associated with tumor progression. Am J Pathol 1998; 153: 887-97.
29. INK4A as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001; 92: 276-84.
30. INK4A expression in normal human adult and infant tissues. Lab Invest 1999; 79: 1137-43.
31. INK4 in human endometrioid-type endometrial carcinoma. Cancer 1997; 80: 2250-6.
32. ink4a in oral squamous cell carcinoma lines by 5-aza-2′- deoxycytidine treatment induces a senescence-like state. Oncogene 1998; 17: 3445-53.
33. INK4A recognizes a modified form of galectin-3. Hybridoma 2001; 20: 167-74.
34. Takeuchi H, Kobayashi R, Hasegawa M, Hirai K. Detection of latent Epstein-Barr virus (EBV) DNA in paraffin sections of nasopharyngeal carcinomas expressing no EBV-encoded small RNAs using in situ PCR. Arch Virol 1997; 142: 1743-56.
35. Remus R, Kammer C, Heller H, Schmitz B, Schell G, Doerfler W. Insertion of foreign DNA into an established mammalian genome can alter the methylation of cellular DNA sequences. J Virol 1999; 73: 1010-22.
36. Klein CB, Costa M. DNA methylation, heterochromatin and epigenetic carcinogens. Mutat Res 1997; 386: 163-80.
37. Toyooka S, Pass HI, Shivapurkar N, Fukuyama Y, Maruyama R, Toyooka KO, Gilcrease M, Farinas A, Minna JD, Gazdar AF. Aberrant methylation and simian virus 40 tag sequences in malignant mesothelioma. Cancer Res 2001; 61: 5727-30.
38. Reid GK, Besterman JM, MacLeod AR. Selective inhibition of DNA methyltransferase enzymes as a novel strategy for cancer treatment. Curr Opin Mol Ther 2002; 4: 130-7.